| Primary |
| Pancreatic Carcinoma Metastatic |
23.5% |
| Breast Cancer |
11.8% |
| Colorectal Cancer Metastatic |
11.8% |
| Neoplasm Progression |
11.8% |
| Rectal Cancer |
11.8% |
| Cervix Cancer Metastatic |
5.9% |
| Colon Cancer Metastatic |
5.9% |
| Drug Use For Unknown Indication |
5.9% |
| Pancreatic Carcinoma |
5.9% |
| Prophylaxis |
5.9% |
|
| Progressive Multifocal Leukoencephalopathy |
38.5% |
| Adverse Reaction |
7.7% |
| Colitis |
7.7% |
| Disease Progression |
7.7% |
| Headache |
7.7% |
| International Normalised Ratio Increased |
7.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
7.7% |
| Sepsis |
7.7% |
| Urinary Tract Infection |
7.7% |
|
| Secondary |
| Colorectal Cancer Metastatic |
29.5% |
| Colorectal Cancer |
29.3% |
| Colon Cancer |
16.9% |
| Pancreatic Carcinoma |
6.1% |
| Breast Cancer |
3.1% |
| Gastric Cancer |
2.9% |
| Breast Cancer Metastatic |
2.5% |
| Pancreatic Carcinoma Metastatic |
1.3% |
| Gallbladder Cancer |
1.2% |
| Rectal Cancer |
1.2% |
| Rectal Cancer Metastatic |
1.1% |
| Prostate Cancer |
1.0% |
| Renal Cancer Metastatic |
1.0% |
| Drug Use For Unknown Indication |
0.7% |
| Hepatic Neoplasm Malignant |
0.6% |
| Colon Cancer Metastatic |
0.6% |
| Biliary Cancer Metastatic |
0.3% |
| Neoplasm Malignant |
0.2% |
| Neuroendocrine Carcinoma |
0.2% |
| Porocarcinoma |
0.2% |
|
| Vomiting |
28.3% |
| Pyrexia |
19.5% |
| White Blood Cell Count Decreased |
8.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Pulmonary Embolism |
3.4% |
| Shock |
3.4% |
| Diarrhoea |
2.9% |
| Intestinal Obstruction |
2.9% |
| Weight Decreased |
2.9% |
| Chest Pain |
2.4% |
| Renal Failure |
2.4% |
| Sepsis |
2.4% |
| Stent Occlusion |
2.4% |
| Subdiaphragmatic Abscess |
2.4% |
| Urinary Tract Infection |
2.4% |
| White Blood Cell Count Increased |
2.4% |
| Gastric Ulcer |
2.0% |
| Hypoaesthesia |
2.0% |
| Small Intestinal Obstruction |
2.0% |
| Thrombocytopenia |
2.0% |
|
| Concomitant |
| Colon Cancer |
13.8% |
| Colorectal Cancer |
13.8% |
| Colorectal Cancer Metastatic |
13.8% |
| Pancreatic Carcinoma Metastatic |
10.3% |
| Chemotherapy |
8.6% |
| Drug Use For Unknown Indication |
6.9% |
| Colon Cancer Metastatic |
5.2% |
| Infection |
5.2% |
| Adenocarcinoma |
3.4% |
| Breast Cancer |
3.4% |
| Breast Cancer Metastatic |
3.4% |
| Lung Neoplasm Malignant |
3.4% |
| Metastatic Renal Cell Carcinoma |
3.4% |
| Hepatic Neoplasm Malignant |
1.7% |
| Multiple Myeloma |
1.7% |
| Renal Cell Carcinoma Stage Unspecified |
1.7% |
|
| Vomiting |
14.8% |
| Metastases To Liver |
7.4% |
| Paraesthesia |
7.4% |
| Sudden Death |
7.4% |
| White Blood Cell Count Increased |
7.4% |
| Abdominal Pain |
3.7% |
| Chest Pain |
3.7% |
| Dementia |
3.7% |
| Disease Progression |
3.7% |
| Drug Toxicity |
3.7% |
| Epistaxis |
3.7% |
| Gastrointestinal Fistula |
3.7% |
| Helicobacter Infection |
3.7% |
| Herpes Zoster |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Lethargy |
3.7% |
| Loss Of Consciousness |
3.7% |
| Mucosal Inflammation |
3.7% |
| Non-cardiac Chest Pain |
3.7% |
| Pancreatic Carcinoma Metastatic |
3.7% |
|
